Inflation of correlation in the pursuit of drug-likeness

Journal of Computer-Aided Molecular Design

Volumn 27, Issue 1, 2013, Pages 1-13

  Kenny, Peter W ^a   Montanari, Carlos A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

ADMET; Correlation; Drug likeness; Lipophilicity; Promiscuity; Solubility

Indexed keywords

DRUG DELIVERY;

ADMET; AQUEOUS SOLUBILITY; CORRELATION; DRUG DISCOVERY; DRUG-LIKENESS; LIPOPHILICITY; MOLECULAR SIZE; PHYSICOCHEMICAL PROPERTY; PROMISCUITY; SURROGATE MEASURES;

SOLUBILITY;

CHEMICAL PARAMETERS; COMPUTER GRAPHICS; CORRELATION COEFFICIENT; CORRELATION INFLATION; DATA ANALYSIS; DRUG LIKENESS; DRUG TARGETING; LIPOPHILICITY; PRIORITY JOURNAL; REVIEW; STATISTICAL ANALYSIS; STATISTICAL PARAMETERS;

EID: 84872038006     PISSN: 0920654X     EISSN: 15734951     Source Type: Journal    
DOI: 10.1007/s10822-012-9631-5     Document Type: Review

References (32)

1. Ziliak ST, McCloskey DN (2008) The cult of statistical significance: How the standard error costs us jobs, justice and lives. University of Michigan Press, Ann Arbor
2. Kelley K, Preacher KJ (2012) On effect size. Psychol Methods 17:137-152
3. Hajduk PJ, Huth JR, Fesik SW (2005) Druggability indices for protein targets derived from NMR-based screening data. J Med Chem 48:2518-2525
4. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23:3-25
5. Abraham MH, Chadha HS, Whiting GS, Mitchell RC (1994) Hydrogen bonding. 32. An analysis of water-octanol and water-alkane partitioning and the Δlog P parameter of Seiler. J Pharm Sci 83:1085-1100
6. Colclough N, Hunter A, Kenny PW, Kittlety RS, Lobedan L, Tam KY, Timms MA (2008) High throughput solubility determination with application to selection of compounds for fragment screening. Bioorg Med Chem 16:6611-6616
7. Smith DA, Di L, Kerns EH (2010) The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery. Nat Rev Drug Discov 9:929-939
8. Ekins S, Honeycutt JD, Metz JT (2010) Multiobjective optimization for drug discovery. In: Abraham DJ, Rotella DP (eds) Burger's medicinal chemistry, drug discovery and development, 7th edn. Wiley, New York
9. Hopkins AL, Groom CR, Alex A (2004) Ligand efficiency: a useful metric for lead selection. Drug Discov Today 9:430-431
10. van de Waterbeemd H, Smith DA, Jones BC (2001) Lipophilicity in PK design: methyl, ethyl, futile. J Comput-Aided Mol Des 15:273-286
11. Hann MM, Leach AR, Harper G (2001) Molecular complexity and its impact on the probability of finding leads for drug discovery. J Chem Inf Comp Sci 41:856-864
12. Woltosz WS (2012) If we designed airplanes like we design drugs. J Comput-Aided Mol Des 26:159-163
13. Kenny PW (2009) Hydrogen bonding, electrostatic potential and molecular design. J Chem Inf Model 49:1234-1244
14. Rodgers JL, Nicewander WA (1988) Thirteen ways to look at the correlation coefficient. Am Stat 42:59-66
15. Hou TJ, Xia K, Zhang W, Xu XJ (2004) ADME evaluation in drug discovery. 4. prediction of aqueous solubility based on atom contribution approach. J Chem Inf Comp Sci 44:266-275
16. ADME/T prediction models and databases. http://modem.ucsd.edu/adme/ databases/databases-logS.htm. Accessed 15 Oct 2012
17. LOGKOW, A databank of evaluated octanol-water partition coefficients. http://logkow.cisti.nrc.ca/logkow/index.jsp. Accessed 26 Oct 2012
18. OEChem Toolkit Manual, OpenEye Scientific Software, Santa Fe, NM 87508. http://www.eyesopen.com/docs/toolkits/current/html/OEChem-TK-c++/index.html. Accessed 26 Oct 2012
19. SMARTS Theory Manual, Daylight Chemical Information Systems, Inc., Laguna Niguel, CA 92677. http://www.daylight.com/dayhtml/doc/theory/theory.smarts. html. Accessed 16 Dec 2012
20. JMP version 10.0.0, SAS Institute, Cary, NC 27513. http://www.jmp.com. Accessed 16 Dec 2012
21. Hopkins AL, Mason JS, Overington JP (2006) Can we rationally design promiscuous drugs? Curr Opin Struct Biol 16:127-136
22. Leeson PD, Springthorpe B (2007) The influence of drug-like concepts on decision-making in medicinal chemistry. Nat Rev Drug Discov 6:881-890
23. Lovering F, Bikker J, Humblet C (2009) Escape from flatland: increasing saturation as an approach to improving clinical success. J Med Chem 52:6752-6756
24. Maxwell JC (1874) Van der Waals on the continuity of gaseous and liquid states. Nature 10:477-480
25. Gleeson MP (2008) Generation of a set of simple, interpretable ADMET rules of thumb. J Med Chem 51:817-834
26. Tarcsay A, Kinga N, Keseru GM (2012) Impact of lipophilic efficiency on compound quality. J Med Chem 55:1252-1260
27. Ritchie TJ, Ertl P, Lewis R (2011) The graphical representation of ADME-related molecule properties for medicinal chemists. Drug Discov Today 16:65-72
28. Hill AP, Young RJ (2010) Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity. Drug Discov Today 15:648-655
29. Ritchie TJ, MacDonald SJF (2009) The impact of aromatic ring count on compound developability: are too many aromatic rings a liability in drug design? Drug Discov Today 14:1011-1020
30. Kenny PW (2012) Computation, experiment and molecular design. J Comput-Aided Mol Des 26:69-72
31. Johnstone C (2012) Medicinal chemistry matters - a call for discipline in our discipline. Drug Discov Today 17:538-543
32. Stahl M, Bajorath J (2011) Computational medicinal chemistry. J Med Chem 54:1-2